WACHSTUM UND WACHSTUMSSTORUNGEN VON KINDERN NACH THERAPIE EINES MEDULLOBLASTOMS

Translated title of the contribution: Growth and growth disorders in children treated for medulloblastoma

A. Koch*, H. G. Dorr, R. Beyer, J. Erhardt, R. Fahlbusch, J. Dunst, J. D. Beck

*Corresponding author for this work
4 Citations (Scopus)

Abstract

Growth disorders in children treated for medulloblastoma are one of the commonest late sequelae and are mainly caused by growth hormone deficiency, which occurs within a few years in almost all patients following cranial irradiation. We report on 16 children treated and followed-up in our hospital. The data were analyzed retrospectively. A decrease in growth was observed in all patients after tumour therapy. 5 patients have reached their final height, which is definitely lower than the normal adult height and their individual target height. Growth hormone deficiency was diagnosed in 11 patients. Standardized endocrinological follow-up programs have to be established to allow for an early diagnosis of endocrine disorders and the begin of adequate therapy in time.

Translated title of the contributionGrowth and growth disorders in children treated for medulloblastoma
Original languageGerman
JournalMonatsschrift fur Kinderheilkunde
Volume142
Issue number11
Pages (from-to)884-889
Number of pages6
ISSN0026-9298
Publication statusPublished - 1994

Fingerprint

Dive into the research topics of 'Growth and growth disorders in children treated for medulloblastoma'. Together they form a unique fingerprint.

Cite this